Markus Maeurer
Impact in
- Infectious Diseases top 0.2%
- Tuberculosis Research and Epidemiology
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 147
- Immunotherapy and Immune Responses 82
- Immune Cell Function and Interaction 63
- T-cell and B-cell Immunology 59
-
- Tuberculosis Research and Epidemiology 87
- Co-authors
- Alimuddin ZumlaMartin RaoPeter MwabaBarbara SeligerWalter J. StorkusMichael HöelscherSoldano FerroneMatthew Bates
- Journals
- International Journal of Infectious Diseases (30 papers)The Lancet Infectious Diseases (13 papers)International Journal of Cancer (11 papers)Clinical Infectious Diseases (8 papers)The Lancet Respiratory Medicine (8 papers)
- Partner nations
- SwedenGermanyUnited Kingdom
In The Last Decade
Markus Maeurer
273 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Infectious Diseases 4.0k
- Immunology 4.2k
- Epidemiology 3.5k
- Oncology 2.0k
- Surgery 1.7k
Countries citing papers authored by Markus Maeurer
This map shows the geographic impact of Markus Maeurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Maeurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Maeurer more than expected).
Fields of papers citing papers by Markus Maeurer
This network shows the impact of papers produced by Markus Maeurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Maeurer. The network helps show where Markus Maeurer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Maeurer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 28 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 10 | |
| 5 | The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB Hit paper breakdown → | 2022 | 236 |
| 6 | 2021 | 6 | |
| 7 | 2020 | 21 | |
| 8 | 2019 | 5 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 33 | |
| 11 | Tuberculosis at post-mortem in inpatient adults at a tertiary referral centre in sub-Saharan Africa - A prospective descriptive autopsy study | 2015 | 1 |
| 12 | 2013 | 16 | |
| 13 | 2012 | 79 | |
| 14 | 2005 | 77 | |
| 15 | 2004 | 14 | |
| 16 | 2002 | 28 | |
| 17 | 2002 | 51 | |
| 18 | 2002 | 6 | |
| 19 | 1999 | 11 | |
| 20 | Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage. | 1995 | 6 |
About Markus Maeurer
Markus Maeurer is a scholar working on Immunology, Infectious Diseases, Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 278 papers that have together received 10.8k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (87 papers), Immunotherapy and Immune Responses (82 papers), Immune Cell Function and Interaction (63 papers), T-cell and B-cell Immunology (59 papers), Mycobacterium research and diagnosis (33 papers), vaccines and immunoinformatics approaches (32 papers), Cancer Immunotherapy and Biomarkers (31 papers) and CAR-T cell therapy research (25 papers). The work is most often cited by research in Infectious Diseases (4.0k citations), Immunology (4.2k citations), Epidemiology (3.5k citations), Oncology (2.0k citations) and Surgery (1.7k citations). Markus Maeurer has collaborated with scholars based in Sweden, Germany and United Kingdom. Frequent co-authors include Alimuddin Zumla, Martin Rao, Peter Mwaba, Barbara Seliger, Walter J. Storkus, Michael Höelscher, Soldano Ferrone, Matthew Bates, Marco Schito and Nathan Kapata. Their work appears in journals such as International Journal of Infectious Diseases, The Lancet Infectious Diseases, International Journal of Cancer, Clinical Infectious Diseases and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.